RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Takeda Pharmaceutical Co ROA 2024

Takeda Pharmaceutical Co ROA

0.02

Takeda Pharmaceutical Co Dividend yield

Ticker

4502.T

ISIN

JP3463000004

WKN

853849

In 2024, Takeda Pharmaceutical Co's return on assets (ROA) was 0.02, a 30.1% increase from the 0.02 ROA in the previous year.

Takeda Pharmaceutical Co Aktienanalyse

What does Takeda Pharmaceutical Co do?

Takeda Pharmaceutical Co Ltd is a Japanese company that operates in the pharmaceutical industry. The company was founded in 1781 by Chobei Takeda as a traditional pharmacy specializing in herbal medicine. Nowadays, the company is a leading player in the global pharmaceutical industry. Business model: Takeda aims to help people worldwide through the development of groundbreaking therapies and drugs. The company has a strong research and development department that focuses on the discovery of new therapies and the improvement of existing medications. Takeda has made global partnerships and acquisitions to leverage the combination of science and technology and ensure better patient care. Divisions: Takeda operates in four main divisions: Gastrointestinal (GI), Oncology, Rare Diseases, and Neuroscience. In the GI division, the company is a global leader in the treatment of gastrointestinal diseases such as Crohn's disease and ulcerative colitis. The Oncology division aims to develop novel cancer therapies and provide patients with a higher quality of life. The Rare Diseases division specializes in the development of medications for rare diseases. The Neuroscience division focuses on developing medications to combat nervous system disorders such as Alzheimer's and Parkinson's. Products: Takeda's product range includes a variety of medications used worldwide to treat various diseases. One example is enzyme replacement therapy, which is administered to patients with a rare disease. Another example is Entyvio, a medication used to treat Crohn's disease and ulcerative colitis. Takeda also has medications in the Oncology division, such as Adcetris, a therapeutic agent against certain lymphomas and leukemia. In summary, Takeda Pharmaceutical Co Ltd is a leading company in the global pharmaceutical industry. The company's business model is based on the development of groundbreaking therapies and medications to improve patient care. With a focus on the GI, Oncology, Rare Diseases, and Neuroscience divisions, Takeda offers a variety of products for the treatment of various diseases. Takeda Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Takeda Pharmaceutical Co's Return on Assets (ROA)

Takeda Pharmaceutical Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Takeda Pharmaceutical Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Takeda Pharmaceutical Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Takeda Pharmaceutical Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Takeda Pharmaceutical Co Stock

What is the Return on Assets (ROA) of Takeda Pharmaceutical Co this year?

The Return on Assets (ROA) of Takeda Pharmaceutical Co is 0.02 undefined this year.

What was the ROA of Takeda Pharmaceutical Co compared to the previous year?

The ROA of Takeda Pharmaceutical Co has increased by 30.1% compared to the previous year.

What consequences do high ROA have for investors of Takeda Pharmaceutical Co?

A high ROA is advantageous for investors of Takeda Pharmaceutical Co, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Takeda Pharmaceutical Co?

A low ROA can be unfavorable for investors of Takeda Pharmaceutical Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Takeda Pharmaceutical Co affect the company?

An increase in ROA of Takeda Pharmaceutical Co can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Takeda Pharmaceutical Co impact the company?

A reduction in the ROA of Takeda Pharmaceutical Co can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Takeda Pharmaceutical Co?

Some factors that can influence the ROA of Takeda Pharmaceutical Co include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Takeda Pharmaceutical Co important for investors?

The ROA of Takeda Pharmaceutical Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Takeda Pharmaceutical Co take to improve ROA?

To improve ROA, Takeda Pharmaceutical Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Takeda Pharmaceutical Co pay?

Over the past 12 months, Takeda Pharmaceutical Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Takeda Pharmaceutical Co is expected to pay a dividend of 177.52 JPY.

What is the dividend yield of Takeda Pharmaceutical Co?

The current dividend yield of Takeda Pharmaceutical Co is .

When does Takeda Pharmaceutical Co pay dividends?

Takeda Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Takeda Pharmaceutical Co?

Takeda Pharmaceutical Co paid dividends every year for the past 24 years.

What is the dividend of Takeda Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 177.52 JPY are expected. This corresponds to a dividend yield of 4.3 %.

In which sector is Takeda Pharmaceutical Co located?

Takeda Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Takeda Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Takeda Pharmaceutical Co from 6/1/2024 amounting to 94 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Takeda Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Takeda Pharmaceutical Co in the year 2023?

In the year 2023, Takeda Pharmaceutical Co distributed 180 JPY as dividends.

In which currency does Takeda Pharmaceutical Co pay out the dividend?

The dividends of Takeda Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Takeda Pharmaceutical Co stock can be added to a savings plan with the following providers: Consorsbank

Andere Kennzahlen von Takeda Pharmaceutical Co

Our stock analysis for Takeda Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Takeda Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.